Melanoma patients showed more variable IL-10 trends, which may indicate heterogeneous regulatory immune responses, including possible immune evasion via T-cell apoptosis [47,48] or downregulation of antigen presentation on dendritic cells [49,50,51]. The gene discussed is IL10; the disease is melanoma.